This study discusses how skin in patients with skin of colour is biologically, functionally and structurally different to that of patients with lightly pigmented skin.

This article reviews the difficulties of driving assessment, including what measures there are to guide GPs, and proposes a practical approach to this issue for general practice.

Hepatitis C virus treatment uptake varies by geographic area in Australia. This study investigated treatment completion according to remoteness, as well as demographic and clinical characteristics.

General Practice Liaison staff undertake a range of activities to improve information flow, care processes and capacity across both sectors.

This study provides insights into the management of heavy menstrual bleeding (HMB) prior to the release of the HMB clinical care standard.

The traumatic experiences associated with COVID-19 pose significant risks for the development of post-traumatic stress disorder (PTSD) and the exacerbation of pre-existing PTSD.

Adverse maternal and neonatal outcomes can be ameliorated through antenatal and postnatal care that attends to the special needs of this group.

Health coaching is an integral part of lifestyle medicine that can be used to facilitate behaviour change in key lifestyle areas.

Menopause is an opportune time for clinicians to assess and promote health, and provide balanced information about treatment choices for symptomatic women.

Despite recent exponential growth in research on familial hypercholesterolaemia, there remains a general lack of public and health professional awareness about the disorder.

Although myeloproliferative neoplasms are rare illnesses, the general practitioner is well placed to identify suspicious features and initiate investigations and referral.

A positive attitude and a sense of perceived behavioural control contribute to successful haemochromatosis self-management with doctors playing an important part.

The health challenges of the dual use of combustible cigarettes and e-cigarettes in Malaysia.

Evidence-informed guideline recommendations on risk treatment thresholds for initiating blood pressure- and lipid-lowering therapy for cardiovascular disease primary prevention is presented.

This article describes the pathophysiology of pelvic congestion syndrome and outlines the symptomatology, the most efficient diagnostic pathway and the optimal treatment methods.